JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: Functional consequences for insulin signaling

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Abdelli, Saida ^a   Bonny, Christophe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AKT1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; PLECKSTRIN HOMOLOGY AND LEUCINE RICH REPEAT PROTEIN PHOSPHATASE; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN KINASE B BETA; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; AKT1 PROTEIN, RAT; AKT2 PROTEIN, RAT; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXO3A PROTEIN, RAT; GLYCOGEN SYNTHASE KINASE 3 BETA; INSULIN RECEPTOR SUBSTRATE; IRS2 PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE 9;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; INSULIN SIGNALING; PANCREAS ISLET BETA CELL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; GENETICS; INSULINOMA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RAT; RNA INTERFERENCE; SECRETION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-SECRETING CELLS; INSULINOMA; MITOGEN-ACTIVATED PROTEIN KINASE 10; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84860488011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035997     Document Type: Article

References (61)

1. Mandrup-Poulsen T, (2001) beta-cell apoptosis: stimuli and signaling. Diabetes 50 (Suppl 1): S58-S63.
2. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, et al. (2005) Mechanisms of {beta}-Cell Death in Type 2 Diabetes. Diabetes 54 (Suppl 2): S108-S113.
3. Eizirik DL, Mandrup-Poulsen T, (2001) A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44: 2115-2133.
4. Eizirik DL, Colli ML, Ortis F, (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5: 219-226 10.1038/nrendo.2009.21.
5. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, et al. (1986) Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 29: 63-67.
6. Mandrup-Poulsen T, (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39: 1005-1029.
7. Ammendrup A, Maillard A, Nielsen K, Aabenhus AN, Serup P, et al. (2000) The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes 49: 1468-1476.
8. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF, (2001) Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50: 77-82.
9. Abdelli S, Abderrahmani A, Hering BJ, Beckmann JS, Bonny C, (2007) The c-Jun N-terminal kinase JNK participates in cytokine- and isolation stress-induced rat pancreatic islet apoptosis. Diabetologia 50: 1660-1669 10.1007/s00125-007-0704-2.
10. Davis RJ, (2000) Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252.
11. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, et al. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15: 2760-2770.
12. Abdelli S, Puyal J, Bielmann C, Buchillier V, Abderrahmani A, et al. (2009) JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis. Diabetologia 52: 1871-1880 10.1007/s00125-009-1431-7.
13. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, et al. (2002) A central role for JNK in obesity and insulin resistance. Nature 420: 333-336.
14. Jaeschke A, Rincon M, Doran B, Reilly J, Neuberg D, et al. (2005) Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes. Proc Natl Acad Sci U S A 102: 6931-6935 10.1073/pnas.0502143102.
15. Aikin R, Maysinger D, Rosenberg L, (2004) Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology 145: 4522-4531.
16. Bernal-Mizrachi E, Fatrai S, Johnson JD, Ohsugi M, Otani K, et al. (2004) Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest 114: 928-936 10.1172/JCI20016.
17. Fornoni A, Pileggi A, Molano RD, Sanabria NY, Tejada T, et al. (2008) Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 51: 298-308.
18. Lee YH, Giraud J, Davis RJ, White MF, (2003) c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 278: 2896-2902.
19. Woodgett JR, (2005) Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 17: 150-157 10.1016/j.ceb.2005.02.010.
20. Dummler B, Hemmings BA, (2007) Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 35: 231-235 10.1042/BST0350231.
21. Yang ZZ, Tschopp O, Baudry A, Dummler B, Hynx D, et al. (2004) Physiological functions of protein kinase B/Akt. Biochem Soc Trans 32: 350-354 10.1042/.
22. Altomare DA, Guo K, Cheng JQ, Sonoda G, Walsh K, et al. (1995) Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene 11: 1055-1060.
23. Altomare DA, Lyons GE, Mitsuuchi Y, Cheng JQ, Testa JR, (1998) Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene 16: 2407-2411 10.1038/sj.onc.1201750.
24. Holst LS, Mulder H, Manganiello V, Sundler F, Ahren B, et al. (1998) Protein kinase B is expressed in pancreatic beta cells and activated upon stimulation with insulin-like growth factor I. Biochem Biophys Res Commun 250: 181-186 10.1006/bbrc.1998.9166.
25. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, et al. (2003) Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17: 590-603 10.1038/sj.leu.2402824.
26. Dickson LM, Rhodes CJ, (2004) Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 287: E192-E198 10.1152/ajpendo.00031.2004.
27. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, et al. (2001) Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15: 2203-2208 10.1101/gad.913901.
28. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, et al. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731 10.1126/science.292.5522.1728.
29. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, et al. (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112: 197-208 10.1172/JCI16885.
30. White MF, (2003) Insulin signaling in health and disease. Science 302: 1710-1711.
31. White MF, Yenush L, (1998) The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr Top Microbiol Immunol 228: 179-208.
32. Burks DJ, White MF, (2001) IRS proteins and beta-cell function. Diabetes 50 (Suppl 1): S140-S145.
33. Toker A, Newton AC, (2000) Cellular signaling: pivoting around PDK-1. Cell 103: 185-188.
34. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, et al. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261-269.
35. Cohen P, Alessi DR, Cross DA, (1997) PDK1, one of the missing links in insulin signal transduction? FEBS Lett 410: 3-10.
36. Kishimoto H, Hamada K, Saunders M, Backman S, Sasaki T, et al. (2003) Physiological functions of Pten in mouse tissues. Cell Struct Funct 28: 11-21.
37. Maehama T, Dixon JE, (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378.
38. Brognard J, Sierecki E, Gao T, Newton AC, (2007) PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25: 917-931 10.1016/j.molcel.2007.02.017.
39. Chu EC, Tarnawski AS, (2004) PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit 10: RA235-RA241.
40. Gao T, Furnari F, Newton AC, (2005) PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18: 13-24 10.1016/j.molcel.2005.03.008.
41. Biggs WH, III, Meisenhelder J, Hunter T, Cavenee WK, Arden KC, (1999) Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci U S A 96: 7421-7426.
42. Jope RS, Johnson GV, (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29: 95-102 10.1016/j.tibs.2003.12.004.
43. Liu Y, Tanabe K, Baronnier D, Patel S, Woodgett J, et al. (2010) Conditional ablation of Gsk-3beta in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice. Diabetologia 53: 2600-2610 10.1007/s00125-010-1882-x.
44. Kim JY, Lim DM, Moon CI, Jo KJ, Lee SK, et al. (2010) Exendin-4 protects oxidative stress-induced beta-cell apoptosis through reduced JNK and GSK3beta activity. J Korean Med Sci 25: 1626-1632 10.3346/jkms.2010.25.11.1626.
45. Tanabe K, Liu Y, Hasan SD, Martinez SC, Cras-Meneur C, et al. (2011) Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3beta independent of JNK activation. PLoS One 6: e18146 10.1371/journal.pone.0018146.
46. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
47. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH, et al. (2002) The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110: 1839-1847 10.1172/JCI16857.
48. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR, (2002) A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2: 81-91.
49. Tsunekawa S, Demozay D, Briaud I, McCuaig J, Accili D, et al. (2011) FoxO feedback control of basal IRS-2 expression in pancreatic beta-cells is distinct from that in hepatocytes. Diabetes 60: 2883-2891 10.2337/db11-0340.
50. Asfari M, Janjic D, Meda P, Li G, Halban PA, et al. (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130: 167-178.
51. Abdelli S, Ansite J, Roduit R, Borsello T, Matsumoto I, et al. (2004) Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes 53: 2815-2823.
52. Aguirre V, Uchida T, Yenush L, Davis R, White MF, (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054.
53. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904.
54. Cantley J, Choudhury AI, Asare-Anane H, Selman C, Lingard S, et al. (2007) Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice. Diabetologia 50: 1248-1256 10.1007/s00125-007-0637-9.
55. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, et al. (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 105: 199-205 10.1172/JCI7917.
56. Tanabe K, Liu Z, Patel S, Doble BW, Li L, et al. (2008) Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance. PLoS Biol 6: e37 10.1371/journal.pbio.0060037.
57. Boucher MJ, Selander L, Carlsson L, Edlund H, (2006) Phosphorylation marks IPF1/PDX1 protein for degradation by glycogen synthase kinase 3-dependent mechanisms. J Biol Chem 281: 6395-6403 10.1074/jbc.M511597200.
58. Glauser DA, Schlegel W, (2007) The emerging role of FOXO transcription factors in pancreatic beta cells. J Endocrinol 193: 195-207 10.1677/JOE-06-0191.
59. Kawamori D, Kajimoto Y, Kaneto H, Umayahara Y, Fujitani Y, et al. (2003) Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase. Diabetes 52: 2896-2904.
60. Robinson GL, Henderson E, Massari ME, Murre C, Stein R, (1995) c-jun inhibits insulin control element-mediated transcription by affecting the transactivation potential of the E2A gene products. Mol Cell Biol 15: 1398-1404.
61. Lingohr MK, Briaud I, Dickson LM, McCuaig JF, Alarcon C, et al. (2006) Specific regulation of IRS-2 expression by glucose in rat primary pancreatic islet beta-cells. J Biol Chem 281: 15884-15892 10.1074/jbc.M600356200.